Condensed Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2019	Mar. 31, 2019
Current Assets:
Cash	$ 3,409	$ 3,409
Due from the Joint Venture	574	373
Income taxes receivable	1,601	1,781
Total current assets	5,584	5,563
Dividend receivable	48,807	81,264
Investment in the Joint Venture	1,253,535	1,211,996
Total assets	1,307,926	1,298,823
Current liabilities:
Accrued expenses	343	176
Due to the Joint Venture	6,167	6,167
Total current liabilities	6,510	6,343
Deferred income tax liabilities	169,992	159,993
Commitments and contingencies (see Note 4)
Stockholders' Equity:
Common Stock	75	75
Preferred stock (par value, $.001), 900,000,000 and 0 shares authorized and no shares issued and outstanding at June 30, 2019 and March 31, 2019, respectively
Additional paid-in capital	1,159,371	1,153,509
Accumulated other comprehensive income (loss)	(8,039)	(3,256)
Retained earnings (deficit)	(19,983)	(17,841)
Total stockholders' equity	1,131,424	1,132,487
Total liabilities and stockholders' equity	1,307,926	1,298,823
Common Class X [Member]
Stockholders' Equity:
Common Stock